Terms: = Gastric cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
5 results:
1. Comparison of survival between diffuse type and intestinal type early-onset gastric cancer patients: A large population-based study.
Wang Q; Wang T
Medicine (Baltimore); 2023 Nov; 102(47):e36261. PubMed ID: 38013337
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic effect of categorized tumor deposits in gastric cancer: A single-center retrospective study.
Hayashi M; Abe M; Fujita T; Matsushita H
Surgery; 2024 Feb; 175(2):373-379. PubMed ID: 37940432
[TBL] [Abstract] [Full Text] [Related]
3. A Signature-Based Classification of gastric cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
Front Immunol; 2021; 12():693314. PubMed ID: 34177954
[TBL] [Abstract] [Full Text] [Related]
4. Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study.
Richards D; Kocs DM; Spira AI; David McCollum A; Diab S; Hecker LI; Cohn A; Zhan F; Asmar L
Eur J Cancer; 2013 Sep; 49(13):2823-31. PubMed ID: 23747051
[TBL] [Abstract] [Full Text] [Related]
5. Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.
Kim CW; Choi SH; Chung EJ; Lee MJ; Byun EK; Ryu MH; Bang YJ
Pathobiology; 1999; 67(3):123-8. PubMed ID: 10394132
[TBL] [Abstract] [Full Text] [Related]
